klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2024)
Related Books
Pädiatrie
Abstracts (HTML)
List of Authors
B
C
D
F
G
H
J
K
L
M
O
P
R
S
V
W
Z
Bahr, AS
Modeling low-grade glioma with cerebral organoids
Baisch, T
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Bezler, V
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Böhme, L
Enhancement of radiation effects by combined treatment with Decitabine and Abacavir in a murine model of human pediatric medulloblastoma
Buhl, J
Modeling low-grade glioma with cerebral organoids
Capper, D
Modeling low-grade glioma with cerebral organoids
Classen, CF
CDKs as target structures for cancer therapy – an
in vitro
analysis on patient-derived glioblastoma cell lines
Debatin, K-M
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Doerner, E
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities
Fitzel, R
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Glasow, A
Enhancement of radiation effects by combined treatment with Decitabine and Abacavir in a murine model of human pediatric medulloblastoma
Gringmuth, M
Enhancement of radiation effects by combined treatment with Decitabine and Abacavir in a murine model of human pediatric medulloblastoma
Halatsch, M-E
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Herbener, VJ
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Hernáiz Driever, P
Modeling low-grade glioma with cerebral organoids
Jones, DTW
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Karpel-Massler, G
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Kortmann, RD
Enhancement of radiation effects by combined treatment with Decitabine and Abacavir in a murine model of human pediatric medulloblastoma
Kramm, C
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities
Lenaerts, I
Design of ovalbumin-loaded mesoporous silica nanoparticles as proof of concept for the development of personalized anti-cancer nanovaccines
Locquet, J-P
Design of ovalbumin-loaded mesoporous silica nanoparticles as proof of concept for the development of personalized anti-cancer nanovaccines
Makalowski, J
Modulated electrohyperthermia as part of immunogenic cell death treatment in pediatric neuro-oncology
Maletzki, C
CDKs as target structures for cancer therapy – an
in vitro
analysis on patient-derived glioblastoma cell lines
Milde, T
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Modeling low-grade glioma with cerebral organoids
Mohr, F
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Oehme, I
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Oppermann, S
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Patties, I
Enhancement of radiation effects by combined treatment with Decitabine and Abacavir in a murine model of human pediatric medulloblastoma
Payer, C
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Peterziel, H
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Pfister, S
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Pietsch, T
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities
Rieß, C
CDKs as target structures for cancer therapy – an
in vitro
analysis on patient-derived glioblastoma cell lines
Schirrmacher, V
Modulated electrohyperthermia as part of immunogenic cell death treatment in pediatric neuro-oncology
Selt, F
Modeling low-grade glioma with cerebral organoids
Seré, S
Design of ovalbumin-loaded mesoporous silica nanoparticles as proof of concept for the development of personalized anti-cancer nanovaccines
Simon, M
Modeling low-grade glioma with cerebral organoids
Stachelscheid, H
Modeling low-grade glioma with cerebral organoids
Strobel, H
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Stuecker, W
Modulated electrohyperthermia as part of immunogenic cell death treatment in pediatric neuro-oncology
Van Gool, SW
Design of ovalbumin-loaded mesoporous silica nanoparticles as proof of concept for the development of personalized anti-cancer nanovaccines
Modulated electrohyperthermia as part of immunogenic cell death treatment in pediatric neuro-oncology
von Bandemer, H
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Waha, A
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities
Westhoff, M-A
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
Combining Autophagy Inhibition and Temozolomide in Glioblastoma Therapy
Re-assessing the Role of Temozolomide in Glioblastoma Therapy
Wiedey, A
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities
Witt, O
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Modeling low-grade glioma with cerebral organoids
Worst, B
Model development and implementation of patient-individual ex vivo drug response profiling within the INFORM registry study
Zimmel, M
Targeting Bcl-2 as Treatment Strategy – Leukaemia versus Glioblastoma
zur Muehlen, A
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities